The relationship between somatic mutations and the IFNγ+ signature shows a moderate correlation (Spearman’s ρ = 0.33), indicating that the immune response in breast cancer may in part be driven by somatic mutation derived neoantigens. Here, IFNG is linked to breast carcinoma.